Figure 12 — FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma

Research Paper|Volume 15, Issue 8|pp. 2937–2969

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma

Back to articleFigure 12(12 of 12)

100%

Figure 12.The correlation of drug sensitivity and cancer pathway activity about FARSB in HCC patients. (A) FARSB-related cancer pathway activity. (B) FARSB-related drug sensitivity using GDSC.